Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:743-756
doi: 10.1161/01.RES.0000214545.99387.e3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, S.
Right arrow Articles by Wandinger-Ness, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, S.
Right arrow Articles by Wandinger-Ness, A.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Receptor pharmacology
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2006;98:743.)
© 2006 American Heart Association, Inc.


Reviews

Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function

Sanchita Mukherjee*, Mathewos Tessema*, Angela Wandinger-Ness

From the Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Correspondence to Angela Wandinger-Ness, Department of Pathology MSC08-4640, 2325 Camino de Salud CRF 225, University of New Mexico Health Sciences Center, Albuquerque, NM 87131-5301. E-mail wness{at}unm.edu

This Review is part of a thematic series on Microdomains in Cardiovascular Signaling, which includes the following articles:

Caveolae and Caveolins in the Cardiovascular System

Focal Adhesion: Paradigm for a Signaling Nexus

Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function

Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of A-Kinase Anchoring Proteins

Targeting Cyclic Nucleotide Signaling

G Protein–Coupled Receptor Trafficking
David A. Kass Editors

Receptor tyrosine kinases (RTKs) play a pivotal role in the development and function of the cardiovascular system. Ligand-activated RTKs promote numerous downstream signal transduction pathways that lead to vascular permeability, as well as proliferation, migration, and differentiation of vascular endothelia and smooth muscle cells. Ligand binding also promotes internalization of the activated receptors either to downregulate the signaling via degradation of the ligand/receptor complex or to signal from endosomes. However, the outcomes of receptor internalization via clathrin-dependent or caveolar pathways and trafficking mechanisms are incompletely clarified in vascular systems. Activity modulation through endocytosis and vesicular trafficking significantly impacts downstream targets of RTKs such as endothelial nitric oxide synthase (eNOS) and VE-cadherin. RTKs and their associated targets are also transported to the nucleus, where they may directly impact nuclear signaling. Although the nuclear transport pathways are just beginning to be unraveled, it appears that endocytosis and vesicular trafficking are involved. In this review, we discuss the mechanisms by which activated RTKs and the downstream targets eNOS and VE-cadherin may be internalized and transported to various intracellular compartments. How localization and interacting proteins impact protein function and influence signaling is an important theme, as is the potential for modulating signaling through therapeutic targeting of activated receptors and components of the endocytic machinery.


Key Words: membrane transport • KDR/Flk-1 • Flt-1 and VEGF receptors • clathrin and caveolae • Erb and EGF receptors • PDGF receptor • insulin and IGF receptors • FGF receptor




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. V. Andreeva, M. A. Kutuzov, V. A. Tkachuk, and T. A. Voyno-Yasenetskaya
T-cadherin is located in the nucleus and centrosomes in endothelial cells
Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1168 - C1177.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. M. Wittko, A. Schanzer, A. Kuzmichev, F. T. Schneider, M. Shibuya, S. Raab, and K. H. Plate
VEGFR-1 Regulates Adult Olfactory Bulb Neurogenesis and Migration of Neural Progenitors in the Rostral Migratory Stream In Vivo
J. Neurosci., July 8, 2009; 29(27): 8704 - 8714.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Kelley, R. Ren, X. Pi, Y. Wu, I. Moreno, M. Willis, M. Moser, M. Ross, M. Podkowa, L. Attisano, et al.
A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling
J. Cell Biol., February 23, 2009; 184(4): 597 - 609.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. Kamat, P. M. Ghosh, R. L. Glover, B. Zhu, C.-K. Yeh, G. G. Choudhury, and M. S. Katz
Reduced Expression of Epidermal Growth Factor Receptors in Rat Liver During Aging
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M.L. Ebos, C. R. Lee, E. Bogdanovic, J. Alami, P. Van Slyke, G. Francia, P. Xu, A. J. Mutsaers, D. J. Dumont, and R. S. Kerbel
Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth
Cancer Res., January 15, 2008; 68(2): 521 - 529.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. K. Shenoy
Seven-Transmembrane Receptors and Ubiquitination
Circ. Res., April 27, 2007; 100(8): 1142 - 1154.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Smith and L. M. Luttrell
Signal Switching, Crosstalk, and Arrestin Scaffolds: Novel G Protein-Coupled Receptor Signaling in Cardiovascular Disease
Hypertension, August 1, 2006; 48(2): 173 - 179.
[Full Text] [PDF]